Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785-798.
Mengesha YM, Bennett ML. Pustular skin disorders: diagnosis and treatment. Am J Clin Dermatol. 2002;3:389-400.
1. Sladden MJ, Johnston GA. Current options for the treatment of impetigo in children. Expert Opin Pharmacother. 2005;6:2245-2256.
2. George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract. 2003;53:480-487.
4. Edlich RF, Winters KL, Britt LD, et al. Bacterial diseases of the skin. J Long Term Eff Med Implants. 2005;15:499-510.
5. Yu Y, Cheng AS, Wang L, et al. Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa. J Am Acad Dermatol. 2007;57:596-600.
6. Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician. 2002;66:119-124.
7. Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol. 2004;5:301-310.
8. Boni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol. 2003;4:273-276.
10. Miller AC, Rashid RM, Khachemoune A. Secondary syphilis. J Emerg Med. 2008;35:83-85.
11. Centers for Disease Control and Prevention. Syphilis. September 2017 [internet publication].
12. Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis. 2002;185:1019-1024.
13. Pleacher MD, Dexter WW. Cutaneous fungal and viral infections in athletes. Clin Sports Med. 2007;26:397-411.
14. Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37:107-121.
15. Swick BL, DeBates SM. A solitary nodule on the finger. Arch Dermatol. 2009;145:321-326.
16. Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785-798.
17. Spellberg BJ, Filler SG, Edwards JE Jr. Current treatment strategies for disseminated candidiasis. Clin Infect Dis. 2006;42:244-251.
18. Spellberg B. Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge. PLoS Pathog. 2008;4:e38.
19. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34:857-863.
20. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003;67:101-108.
21. Karthikeyan K. Scabies in children. Arch Dis Child Educ Pract Ed. 2007;92:65-69.
22. Shahzad N, Nasir J, Ikram U, et al. Frequency and psychosocial impact of acne on university and college students. J Coll Physicians Surg Pak. 2011;21:442-443.
23. Clarke SB, Nelson AM, George RE, et al. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications. Dermatol Clin. 2007;25:137-146, v.
24. Webster GF. Pustular drug reactions. Clin Dermatol. 1993;11:541-543.
25. Fraser SJ, Benton EC, Roddie PH, et al. Eosinophilic folliculitis: an important differential diagnosis after allogeneic bone-marrow transplant. Clin Exp Dermatol. 2009;34:369-371.
26. Nervi SJ, Schwartz RA, Dmochowski M. Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol. 2006;55:285-289.
27. Lankerani L, Thompson R. Eosinophilic pustular folliculitis: case report and review of the literature. Cutis. 2010;86:190-194.
28. Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26:555-560.
29. El Menyawi MM, Raslan HM, Edrees A. Clinical features of Behcet's disease in Egypt. Rheumatol Int. 2009;29:641-646.
30. Alexander AM, Delph WI. Pseudofolliculitis barbae in the military. A medical, administrative and social problem. J Natl Med Assoc. 1974;66:459-479.
31. Edlich RF, Haines PC, Nichter LS, et al. Pseudofolliculitis barbae with keloids. J Emerg Med. 1986;4:283-286.
32. Perry PK, Cook-Bolden FE, Rahman Z, et al. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol. 2002;46:113-119.
33. Ratnarathorn M, Newman J. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) occurring in association with nodal marginal zone lymphoma: a case report. Dermatol Online J. 2008;14:6.
34. Good LM, Good TJ, High WA. Infantile acropustulosis in internationally adopted children. J Am Acad Dermatol. 2011;65:763-771.
35. Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol. 1998;15:337-341.
36. Marchini G, Nelson A, Edner J, et al. Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant. Pediatr Res. 2005;58:613-616.
37. Mengesha YM, Bennett ML. Pustular skin disorders: diagnosis and treatment. Am J Clin Dermatol. 2002;3:389-400.
38. deShazo RD, Williams DF, Moak ES. Fire ant attacks on residents in health care facilities: a report of two cases. Ann Intern Med. 1999;131:424-429.
39. Ayhan M, Sancak B, Karaduman A, et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol. 2007;57:1012-1018.
40. Conlon JD, Drolet BA. Skin lesions in the neonate. Pediatr Clin North Am. 2004;51:863-388, vii-viii.
41. Feng E, Janniger CK. Miliaria. Cutis. 1995;55:213-216.
42. Kirk JF, Wilson BB, Chun W, et al. Miliaria profunda. J Am Acad Dermatol. 1996;35:854-856.
43. Oltz M, Check J. Rosacea and its ocular manifestations. Optometry. 2011;82:92-103.
44. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139:1444-1450.
45. Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007 Aug;13(8):975-80.
46. Wu IB, Schwartz RA. Reiter's syndrome: the classic triad and more. J Am Acad Dermatol. 2008;59:113-121.
47. Brill TJ, Elshorst-Schmidt T, Valesky EM, et al. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments. Dermatology. 2005;211:351-355.
48. Dirschka T. Periorale dermatitis. Bochum: Ruhr-Universität; 2004.
49. Rodriguez-Martin M, Saez-Rodriguez M, Carnerero-Rodriguez A, et al. Treatment of perioral dermatitis with topical pimecrolimus. J Am Acad Dermatol. 2007;56:529-530.
50. Kerl K, Masouyé I, Lesavre P, et al. A case of amicrobial pustulosis of the folds associated with neutrophilic gastrointestinal involvement in systemic lupus erythematosus. Dermatology. 2005;211:356-359.
51. Lee HY, Pelivani N, Beltraminelli H, et al. Amicrobial pustulosis-like rash in a patient with Crohn's disease under anti-TNF-alpha blocker. Dermatology. 2011;222:304-310.
52. Agero AL, Dusza SW, Benvenuto-Andrade C, et al. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. 2006;55:657-670.
53. Van Doorn R, Kirtschig G, Scheffer E, et al. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol. 2002;147:598-601.
54. Röckl H. Leukocytoclastic vasculitis due to drug allergy presenting as generalized pustular exanthema [in German]. Hautarzt. 1981;32:467-470.
55. Roujeau IC, Bioulac-Sage P, Boursean C, et al. Acute generalised exanthematous pustulosis: analysis of 63 cases. Arch Dermatol. 1991;127:1333-1338.
56. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 2003;206:353-356.
57. Maoz KB, Brenner S. Drug rash with eosinophilia and systemic symptoms syndrome: sex and the causative agent. Skinmed. 2007;6:271-273.
58. Chu CY. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol. 2007;21:484-490.
59. Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res. 2003;295:43-54.
60. Iizuka H, Takahashi H, Ishida-Yamamoto A. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res. 2003;295:55-59.
61. Serra D, Gonçalo M, Mariano A, et al. Pustular psoriasis and drug-induced pustulosis. G Ital Dermatol Venereol. 2011;146:155-158.
62. Ozawa A, Miyahara M, Sugai J, et al. HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLA-Cw1 and HLA-DQB1*0303. J Dermatol. 1998;25:573-581.
63. Larsen CG, Thyssen JP. Pustular penile pyoderma gangrenosum successfully treated with topical tacrolimus ointment. Acta Derm Venereol. 2012;92:104-105.
64. Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79:37-46.
65. Nanda S, Reddy BS, Ramji S, et al. Analytical study of pustular eruptions in neonates. Pediatr Dermatol. 2002;19:210-215.
66. Asumalahti K, Ameen M, Suomela S, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003;120:627-632.
67. Eleftheriou LI, McIntee TJ, Stratman EJ. Aminolevulinic acid photodynamic therapy in the treatment of erosive pustular dermatosis of the scalp. Arch Dermatol. 2011;147:1368-1370.
68. Odom RB, James WD, Berger TG. Andrew's disease of the skin: clinical dermatology. 9th ed. Philadelphia, PA: W.B. Saunders Company; 2000.
69. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. London: Mosby; 2007.
70. Coquilla BH, Lewis CW. Management of pseudofolliculitis barbae. Mil Med. 1995;160:263-269.
71. Quarles FN, Brody H, Johnson BA, et al. Pseudofolliculitis barbae. Dermatol Ther. 2007;20:133-136.
72. Van Praag MC, Van Rooij RW, Folkers E, et al. Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol. 1997;14:131-143.
73. Méan M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care. 2008;12:204.
74. Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol. 2001;28:113-119.
75. Tamir E, Wohl Y, Mashiah J, et al. Acute generalized exanthematous pustulosis: a retrospective analysis showing a clear predilection for women. Skinmed. 2006;5:186-188.
76. Fung MA, Berger TG. A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids. Dermatology. 2000;200:43-44.
78. Smolinski KN, Shah SS, Honig PJ, et al. Neonatal cutaneous fungal infections. Curr Opin Pediatr. 2005;17:486-493.
79. López-Navarro N, Alcaide A, Gallego E, et al. Amicrobial pustulosis of the folds associated with Hashimoto's thyroiditis. Clin Exp Dermatol. 2009;34:e561-e563.
80. Alves EV, Martins JE, Ribeiro EB, et al. Pityrosporum folliculitis: renal transplantation case report. J Dermatol. 2000;27:49-51.
81. Schwarz T, Kreiselmaier I, Bieber T, et al. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. J Am Acad Dermatol. 2008;59:34-40.
82. Boer A, Herder N, Winter K, et al. Herpes folliculitis: clinical, histopathological, and molecular pathologic observations. Br J Dermatol. 2006;154:743-746.
83. Weinberg JM, Mysliwiec A, Turiansky GW, et al. Viral folliculitis. Atypical presentation of herpes simplex, herpes zoster and molluscum contagiosum. Arch Dermatol. 1997;133:983-986.
84. Nakamura K, Imakado S, Takizawa M, et al. Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules. J Am Acad Dermatol. 2000;42:1021-1025.
85. Poli F, Prost C, Revuz J. Gram-negative bacteria folliculitis [in French]. Ann Dermatol Venereol. 1988;115:797-800.
86. Khera P, Haught JM, McSorley J, et al. Atypical presentations of herpesvirus infections in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 2009;60:484-486.
87. Bundino S, Zina AM, Ubertalli S. Infantile acropustulosis. Dermatologica. 1982;165:615-619.
88. Sotiriadis D, Patsatsi A, Sotiriou E, et al. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate. J Dermatolog Treat. 2007;18:315-318.
89. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J. 2007;48:573-585.
90. Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001;45:723-730.
91. Halevy S, Cohen A, Livni E. Acute generalized exanthematous pustulosis associated with polysensitivity to paracetamol and bromhexine: the diagnostic role of in vitro interferon-gamma release test. Clin Exp Dermatol. 2000;25:652-654.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台